Maravai LifeSciences Holdings, Inc.
MRVI
$2.06
$0.052.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -27.00% | -23.92% | -2.49% | 6.51% | -18.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.00% | -23.92% | -2.49% | 6.51% | -18.79% |
| Cost of Revenue | 2.06% | 6.65% | 0.38% | -11.56% | 13.83% |
| Gross Profit | -70.11% | -51.42% | -5.98% | 37.00% | -43.01% |
| SG&A Expenses | -3.23% | 19.97% | 0.57% | 14.64% | 5.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.80% | 12.38% | 0.45% | 1.53% | 10.14% |
| Operating Income | -82.97% | -44,103.28% | -15.54% | 23.11% | -892.46% |
| Income Before Tax | -135.13% | -107.09% | -754.17% | -26.66% | -395.45% |
| Income Tax Expenses | -40.22% | -100.00% | 105.69% | -71.36% | 108.54% |
| Earnings from Continuing Operations | -133.04% | 57.72% | -1,065.11% | -21.34% | -1,582.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 116.07% | 405.84% | 790.24% | 27.86% | 727.63% |
| Net Income | -147.93% | 75.33% | -1,432.62% | -15.96% | -17,926.87% |
| EBIT | -82.97% | -44,103.28% | -15.54% | 23.11% | -892.46% |
| EBITDA | -185.15% | -233.25% | -49.31% | 140.21% | -173.98% |
| EPS Basic | -128.70% | 77.00% | -1,327.76% | -12.50% | -18,160.00% |
| Normalized Basic EPS | 50.00% | -99.93% | 2,275.24% | 2.40% | -168.38% |
| EPS Diluted | -128.70% | 77.00% | -1,300.00% | -12.50% | -18,160.00% |
| Normalized Diluted EPS | 50.00% | -99.93% | 2,275.24% | 2.40% | -168.38% |
| Average Basic Shares Outstanding | 8.38% | 7.32% | 7.30% | 3.02% | 0.45% |
| Average Diluted Shares Outstanding | 8.38% | 7.32% | 7.30% | 3.02% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |